Product Information
RIVAROXABAN 1 MG/ML SUSPENSION is a generic product labeled by Ascend Laboratories, LLC, priced at $1.7938 per ML under NDC 67877088271. Its NADAC has been published 28 times since Dec 17, 2025.
The High Outlier badge above means this manufacturer's average price in the Rivaroxaban market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
155 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877088271
Classification
Generic
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVAROXABANApproval Type
Generic (ANDA)
FDA Application
ANDA218502On Market Since
7/7/2025
Pharmacological Classes
Price Statistics
The NADAC for RIVAROXABAN 1 MG/ML SUSPENSION has been published 28 times since Dec 17, 2025, and over the history we have for it it has declined 13.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7938 per ML |
|---|---|
| All-time high | $2.0669 (Feb 11, 2026) |
| All-time low | $1.7938 (Jun 17, 2026) |
| 52-week high | $2.0669 |
| 52-week low | $1.7938 |
| Median price | $1.9574 |
| Average price | $1.9634 |
| Largest weekly change | -4.0% (Apr 22, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Rivaroxaban market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RIVAROXABAN 1 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for RIVAROXABAN 1 MG/ML SUSPENSION, manufactured by Ascend Laboratories, LLC, is $1.7938 per ML (NDC 67877088271), effective Jun 24, 2026.
How has the price of RIVAROXABAN 1 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for RIVAROXABAN 1 MG/ML SUSPENSION has declined 13.2%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for RIVAROXABAN 1 MG/ML SUSPENSION?
Since Dec 17, 2025, the NADAC for RIVAROXABAN 1 MG/ML SUSPENSION has ranged from a low of $1.7938 (Jun 17, 2026) to a high of $2.0669 (Feb 11, 2026), with a median of $1.9574 per ML.
Are there cheaper alternatives to RIVAROXABAN 1 MG/ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RIVAROXABAN 1 MG/ML SUSPENSION, so no direct lower-cost alternative is listed.
Who manufactures RIVAROXABAN 1 MG/ML SUSPENSION?
RIVAROXABAN 1 MG/ML SUSPENSION (NDC 67877088271) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification